During the last session, Core Laboratories Inc (NYSE:CLB)’s traded shares were 0.82 million, with the beta value of the company hitting 1.41. At the end of the trading day, the stock’s price was $12.41, reflecting an intraday loss of -1.35% or -$0.17. The 52-week high for the CLB share is $25.13, that puts it down -102.5 from that peak though still a striking 18.29% gain since the share price plummeted to a 52-week low of $10.14. The company’s market capitalization is $581.82M, and the average intraday trading volume over the past 10 days was 0.48 million shares, and the average trade volume was 500.88K shares over the past three months.
Core Laboratories Inc (CLB) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 3.17. CLB has a Sell rating from 1 analyst(s) out of 4 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it.
Core Laboratories Inc (NYSE:CLB) trade information
Core Laboratories Inc (CLB) registered a -1.35% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -1.35% in intraday trading to $12.41, hitting a weekly high. The stock’s 5-day price performance is 3.42%, and it has moved by 8.38% in 30 days. Based on these gigs, the overall price performance for the year is -32.11%. The short interest in Core Laboratories Inc (NYSE:CLB) is 7.54 million shares and it means that shorts have 15.75 day(s) to cover.
The consensus price target of analysts on Wall Street is $26, which implies an increase of 52.27% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $17 and $32 respectively. As a result, CLB is trading at a discount of -157.86% off the target high and -36.99% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -20.53%. While earnings are projected to return -17.23% in 2025, the next five years will return 3.35% per annum.
CLB Dividends
Core Laboratories Inc is due to release its next quarterly earnings on 2025-Apr-23. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Core Laboratories Inc is 0.04, with the dividend yield indicating at 0.32 percent, continuing the trend of increasing dividends in recent years. The average dividend yield of the company for the last 5 years is 0.57%.
Core Laboratories Inc (NYSE:CLB)’s Major holders
Core Laboratories Inc insiders own 1.01% of total outstanding shares while institutional holders control 117.74%, with the float percentage being 118.94%. ARIEL INVESTMENTS, LLC is the largest shareholder of the company, while 278.0 institutions own stock in it. As of 2024-06-30, the company held over 10.29 million shares (or 21.9415% of all shares), a total value of $208.83 million in shares.
The next largest institutional holding, with 7.8 million shares, is of BLACKROCK INC.’s that is approximately 16.6241% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $158.22 million.
